en · de · es · pt
methods-notes.peptides4800.com › Data › Identification And Molecular Background — Complete Guide

Identification And Molecular Background — Complete Guide

By Editorial Desk · published 2025-07-14 · last reviewed 2025-08-21 · Data

thymosin beta-4 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2025-08-21 and is reviewed periodically as new material appears.

Identification and Molecular Background

Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.

TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.

Handling, Storage, and Analysis

Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.

Tb-500 at a glance

PropertyValueNotes
Generic designationSynthetic thymosin beta-4 N-terminal fragmentPeptide nomenclature varies by supplier
Peptide lengthApproximately 17 amino acid residuesReported length sometimes differs between sources
N-terminal modificationAcetyl groupAffects mass and chromatographic behaviour
Compound classSmall synthetic peptideNot a small-molecule drug
Common synonymsTB4 fragment; thymosin beta-4 fragmentNaming is inconsistent in popular media

Thymosin Beta-4 Fragment Identity

No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.

TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.

Related pages on this site

Thymosin Beta-4 Fragment Background

Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.

Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.

Handling, Stability and Analytical Detection

Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.

Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.

Detection, Stability, and Regulatory Status

Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.

Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.

Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.

Further detail

=== Layne Staley Day in Seattle === On August 22, 2019, which would have been Staley's 52nd birthday, Seattle mayor Jenny Durkan officially proclaimed that day as "Layne Staley Day" in the city in honor of Staley's contributions to the world of music. The day was also a call to attention to the Layne Staley Memorial Fund, established by his parents in 2002.

== Solid waste == The World Bank collected data on the generation of municipal solid waste around the world. Of the ASEAN countries with data, Thailand's municipalities ranked number one in the region for waste generation at 1.76 kilograms per day per person. Others were Malaysia (1.52 kg/day); Singapore (1.49 kg/day); Vietnam (1.46 kg/day); Laos (0.70 kg/day); Indonesia (0.52 kg/day); Philippines (0.50 kg/day); Myanmar (0.44 kg/day). The World Bank projects that by 2025 Thailand's municipal generation of solid waste will reach 1.95 kg per person per day.

== Institutions with hypobaric chambers == terraXcube, Eurac Research, accredited laboratory for environmental testing with large climatic chambers and medical clinic Centro de Medicina Aeroespacial de la Fuerza Aerea Colombiana, Aviation medicine, physiological, and hypobaric services Royal New Zealand Air Force Aviation Medicine Unit , Aviation medicine training and hypobaric services U.S. Army Institute of Environmental Medicine, Natick, MA, 33 years experience with its Hypobaric Chamber Facility Sheppard Air Force Base in Wichita Falls, Texas University of North Dakota's John D. Odegard School of Aerospace Sciences, Aviation Training Naval Operational Medicine Institute, Operational medical and survival training and consultative services to military forces worldwide Arizona State University Polytechnic Campus, Aircrew training, research, and other uses National AeroSpace Training And Research (NASTAR) Center South, Air and space training, research, and education RAF Centre of Aviation Medicine Center for Man in Aviation, Royal Netherlands Air Force, Aircrew training, physiology, research and certification of equipment University Hospitals Cleveland Medical Center in Cleveland, Ohio, aerospace physiology research AXA Training Center, Training ground of Liverpool F.C.

== International standard == DASH7 Alliance Protocol originates from the ISO/IEC 18000-7 standard describing a 433 MHz ISM band air interface for active RFID. This standard was mainly used for military logistics. The DASH7 Alliance re-purposed the original 18000-7 technology in 2011 and made it evolve toward a wireless sensor network technology for commercial applications. The DASH7 Alliance Protocol covers all sub-GHz ISM bands, making it available globally. The name of the new protocol was derived from the section seven denoted as -7 () of the original standard document. The current version of the DASH7 Alliance protocol is no longer compliant with the ISO/IEC 18000-7 standard.

Sources: en.wikipedia.org

Background from the literature

Reticular opacities, often associated with traction bronchiectasis Honeycombing manifested as cluster cystic airspaces, typically of comparable diameters (3–10 mm (0.12–0.39 in)) but occasionally large. Usually sub-pleural and characterized by well-defined walls and disposed in at least two lines. Generally one line of cysts is not sufficient to define honeycombing Ground-glass opacities are common but less extensive than the reticulation Distribution characteristically basal and peripheral though often patchy.

== Structural studies == As of late 2007, 9 structures have been solved for this class of enzymes, with PDB accession codes PDB: 1G6K​, PDB: 1GCO​, PDB: 1GEE​, PDB: 1RWB​, PDB: 1SPX​, PDB: 2B5V​, PDB: 2B5W​, PDB: 2CD9​, and PDB: 2CDA​.

=== Protein complex purification === Complexes of interacting proteins may also be purified using the SBP-Tag because elution with biotin permits recovery under conditions in which desired complexes remain associated. For example, the Condensin Complex was purified by Kim et al. [2010] and complexes with the TAZ transcriptional co-activator were purified by Zhang et al. [2009]. The SBP-Tag has also been incorporated into several Tandem Affinity Purification (TAP) systems in which successive purification steps are utilized with multiple tags, for example GFP fusion proteins and BTK-protein complexes were purified using a TAP protocol with the SBP-Tag and the His-Tag, HDGF-protein complexes were purified using a TAP protocol with the SBP-Tag and with the FLAG-tag and Wnt complexes were purified using a TAP protocol with the SBP-Tag and with the [Calmodulin-Tag]. TAP is generally used with protein complexes and several studies report significant improvements in purity and yield when the SBP-Tag TAP systems are compared to non-SBP-Tag systems. Commercial TAP systems that use the SBP-Tag include the Interplay® Adenoviral and Mammalian TAP Systems sold by Agilent Technologies, similar products are sold by Sigma-Aldrich.

== Types == Nano-materials are often categorized as to how many of their dimensions fall in the nanoscale. A nanoparticle is defined a nano-object with all three external dimensions in the nanoscale, whose longest and the shortest axes do not differ significantly. A nanofiber has two external dimensions in the nanoscale, with nanotubes being hollow nanofibers and nanorods being solid nanofibers. A nanoplate/nanosheet has one external dimension in the nanoscale, and if the two larger dimensions are significantly different it is called a nanoribbon. For nanofibers and nanoplates, the other dimensions may or may not be in the nanoscale, but must be significantly larger. In all of these cases, a significant difference is noted to typically be at least a factor of 3. Nanostructured materials are often categorized by what phases of matter they contain. A nanocomposite is a solid containing at least one physically or chemically distinct region or collection of regions, having at least one dimension in the nanoscale. A nanofoam has a liquid or solid matrix, filled with a gaseous phase, where one of the two phases has dimensions on the nanoscale. A nanoporous material is a solid material containing nanopores, voids in the form of open or closed pores of sub-micron lengthscales. A nanocrystalline material has a significant fraction of crystal grains in the nanoscale.

He created the library's first Young Readers Center in the Jefferson Building in 2009, and the first large-scale summer intern (Junior Fellows) program for university students in 1991. Under Billington, the library sponsored the Gateway to Knowledge in 2010 to 2011, a mobile exhibition to ninety sites, covering all states east of the Mississippi, in a specially designed eighteen-wheel truck. This increased public access to library collections off-site, particularly for rural populations, and helped raise awareness of what was also available online. Billington raised more than half a billion dollars of private support to supplement Congressional appropriations for library collections, programs, and digital outreach. These private funds helped the library to continue its growth and outreach in the face of a 30% decrease in staffing, caused mainly by legislative appropriations cutbacks. He created the library's first development office for private fundraising in 1987. In 1990, he established the James Madison Council, the library's first national private sector donor-support group. In 1987, Billington also asked the Government Accountability Office (GAO) to conduct the first library-wide audit. He created the first Office of the Inspector General at the library to provide regular, independent reviews of library operations. This precedent has resulted in regular annual financial audits at the library; it has received unmodified ("clean") opinions from 1995 onward.

Sources: en.wikipedia.org

Frequently asked questions

What is TB-500 chemically?

It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.

Is TB-500 the same as thymosin beta-4?

No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.

Where does the name come from?

The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.

How is the material stored?

The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.

Network